NCT05534100

Brief Summary

The aim of the project is to advance our understanding of how individuals with Posttraumatic Stress Disorder (PTSD) experience symptoms in their every-day lives when they are in their home environment. To date, all PTSD assessments are retrospective; individuals with PTSD are asked to recount and report their symptoms over the past weeks or months. Such assessment procedures are negatively impacted by individuals' abilities to accurately recall information. Moreover, retrospective assessments provide little information about how symptoms are experienced in the moment and how these experiences then lead to other behaviors. The proposed project addresses these limitations by assessing PTSD symptoms and associated biological markers (e.g., sleep, heart rate, heart rate variability) in real-time by asking subjects to wear a smart device and complete brief surveys. Data will be collected from 50 individuals with PTSD and 20 healthy controls to help us better understand individuals' real-time experience with PTSD and lay the foundation to develop algorithms for possible in-the-moment interventions in the future.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 6, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 9, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2023

Completed
Last Updated

October 18, 2023

Status Verified

October 1, 2023

Enrollment Period

10 months

First QC Date

September 6, 2022

Last Update Submit

October 16, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Clinician Administered PTSD Scale for DSM-5

    Clinician administered measure of PTSD

    Through study completion, average of 1 month

  • PTSD Checklist for DSM-5 Criteria

    Self-report measure of PTSD

    Through study completion, average of 1 month

Study Arms (2)

Healthy Control

Device: Biostrap EVO Wristband

PTSD

Device: Biostrap EVO Wristband

Interventions

Participants in both groups will wear the Biostrap wearable device

Healthy ControlPTSD

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Individuals who either present as a healthy control or are deemed to have PTSD by the CAPS

You may qualify if:

  • Are 18 years or older
  • Are fluent in English
  • Have an active smart phone or smart device with full data and Bluetooth capability
  • Have experienced a Criterion A traumatic event during their lifetime
  • Have a PTSD diagnosis verified by the Clinician Administered PTSD Scale for DSM-5 and a symptom severity score of 35 or higher.
  • Are willing and able to complete self-report measures and clinician-rated assessments at multiple time points over the course of the study
  • Are willing to wear a smart device 24/7 over the course of one month.

You may not qualify if:

  • The traumatic event occurred in the past month
  • They are currently suicidal or homicidal
  • They have a history of psychosis or mania
  • They have a known, diagnosed heart condition
  • They are currently receiving treatment for their PTSD or have completed an evidence- based PTSD treatment in the past 3 months
  • They have a serious or unstable medical illness or instability for which hospitalization may be likely
  • Subjects who, at the time of consent, appear to have extenuating life circumstances (unstable housing, no internet access, etc.) which, in the judgement of the Principal Investigator, could affect their ability to participate in the study
  • Individuals are eligible for the current study if they:
  • Are 18 years or older
  • Are fluent in English
  • Have an active smart phone or smart device with full data and Bluetooth capability
  • Are willing and able to complete self-report measures and clinician-rated assessments at multiple time points over the course of the study
  • Are willing to wear a smart device 24/7 over the course of one month.
  • Individuals are excluded from the current study if they:
  • Score a 10 or higher on the Clinician Administered PTSD Scale for DSM-5
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rush University Medical Center

Chicago, Illinois, 60612, United States

Location

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Director

Study Record Dates

First Submitted

September 6, 2022

First Posted

September 9, 2022

Study Start

November 1, 2022

Primary Completion

September 1, 2023

Study Completion

September 1, 2023

Last Updated

October 18, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

Locations